Literature DB >> 29149111

[Bilateral bronchopneumonia due to Rothia mucilaginosa].

B De Escalante Yangüela1, A Gracia Gutiérrez, B Gracia Tello, V Alastrué Del Castaño, E Bueno Juana, S Algárate Cajo.   

Abstract

Rothia mucilaginosa (R. mucilaginosa), formerly named Stomatococcus mucilaginosus, is a facultatively anaerobic, encapsulated gram-positive coccus, which forms part of the normal oropharyngeal and is rarely considered to be a pathogen in immunocompetent patients, although it can produce, on rare occasions, serious infections like bacteremia, endocarditis and respiratory infections; such as pneumonia, pleural empyema or superinfection of bronchiectasis. We present the case of a 74-year-old male diagnosed with right basal pneumonia of torpid evolution with a poor initial response to different antibiotics, with clinical and radiological worsening and the appearance of bilateral bronchopneumonia with pseudonodular images. R. mucilaginosa in pure culture was isolated in three sputum cultures and in bronchial suction. The patient was finally treated with Linezolid with a good clinical response and normalisation of the thorax radiography, confirming the disappearance of R. mucilaginosa in subsequent sputum cultures. As there are few documented cases of pneumonia due to R. mucilaginosa, we believe that presenting this case will be of interest.

Entities:  

Mesh:

Year:  2017        PMID: 29149111     DOI: 10.23938/ASSN.0090

Source DB:  PubMed          Journal:  An Sist Sanit Navar        ISSN: 1137-6627            Impact factor:   0.829


  2 in total

1.  Respiratory Bacterial Microbiota and Individual Bacterial Variability in Lung Cancer and Bronchiectasis Patients.

Authors:  Anuradha Ekanayake; Dushantha Madegedara; Vishvanath Chandrasekharan; Dhammika Magana-Arachchi
Journal:  Indian J Microbiol       Date:  2019-12-11       Impact factor: 2.461

2.  Chest Computed Tomography Images in Neonatal Bronchial Pneumonia under the Adaptive Statistical Iterative Reconstruction Algorithm.

Authors:  Ying Sun; Liao Wu; Zhaofang Tian; Tianping Bao
Journal:  J Healthc Eng       Date:  2021-10-27       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.